Cognitive brain circuits and the spread of tau in vivo in humans.

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511613-38-01

Enrollment

160

Registered

2024-08-27

Start date

2018-05-18

Completion date

Unknown

Last updated

2024-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease in a preclinical and prodromal stage

Brief summary

Effect of tau aggregates on activity amplitude in the perisylvian network 2. Effect of tau aggregates on functional connectivity measures

Detailed description

Effect of tau aggregates on EEG based measures of functional connectivity

Interventions

DRUG[18F]MK-6240

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Effect of tau aggregates on activity amplitude in the perisylvian network 2. Effect of tau aggregates on functional connectivity measures	—

Secondary

Measure	Time frame
Effect of tau aggregates on EEG based measures of functional connectivity	—

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026